統合失調症における認知機能障害の原因解明と治療法への探求

Keyphrases

1. Adeno-associated Viral Vector 10%
2. Behavioral Impairment 16%
3. Cognitive Dysfunction 8%
4. Conditioned Place Preference 8%
5. Depressive-like Behavior 18%
6. DNA Methylation (DNAm) 16%
7. Dopamine D1 Receptor 16%
8. Dorsal Striatum 5%
9. Female Mice 12%
10. Functional Disorders 16%
11. Hyperlocomotion 19%
12. Knock-in Mouse Model 18%
13. KO Mice 6%
14. Methamphetamine 59%
15. Methamphetamine Dependence 5%
16. MGluR3 16%
17. MRNA Expression 7%
18. Murine Model 16%
19. Myelination 16%
20. N-acetylaspartate 24%
21. N-acetylaspartylglutamate 5%
22. N-acetyltransferase 2 (NAT2) 34%
23. Neuronal Diseases 16%
24. Nicotinic Acetylcholine Receptor (nAChR) 16%
25. Nucleus Accumbens 54%
26. Osteopontin 16%
27. Overexpression 24%
28. Patients with Schizophrenia 16%
29. Peripheral Blood 9%
30. Place Preference 16%
31. Protein Knockout 16%
32. Psychiatric Disease 16%
33. Schizophrenia 21%
34. Schizophrenia Models 16%
35. Sensorimotor Gating Deficit 16%
36. Serotonergic 16%
37. Shati 100%
38. Striatal 16%
39. Synthetase 16%
40. Transmembrane Protein 33%

Neuroscience

1. Adeno Associated Virus Vector 16%
2. Aspartic Acid 8%
3. Behavior (Neuroscience) 24%
4. Coenzyme A 6%
5. Cognitive Disorders 16%
6. Conditioned Place Preference 20%
7. CpG Island 16%
8. CREB 16%
9. DNA Methylation 16%
10. Dopamine Receptor D1 16%
11. Dorsal Striatum 16%
12. Electrophysiology 8%
13. Gamma-Aminobutyric Acid 5%
14. Genomic DNA 8%
15. Glutamate Carboxypeptidase II 8%
16. Major Depressive Disorder 8%
17. Messenger RNA 21%
18. Metabotropic Glutamate Receptor 3 8%
19. Methamphetamine Dependence 7%
20. Methylation 16%
21. Myelinogenesis 16%
22. N-Acetylaspartic Acid 16%
23. N-Acetyltransferase 37%
24. Nicotinic Acetylcholine Receptor 16%
25. Nucleus Accumbens 55%
26. Osteopontin 16%
27. Promoter Region 18%
28. Sensory Gating 16%
29. Serotonergic 16%
30. Social Interaction 5%
31. Synthetase 16%
32. Transmembrane Protein 33%